Phase 2 Readout~quarter
Phase 2 Readout: enobosarm + semaglutide
- Company
- VERU INC. (VERU)
- Indication
- obesity
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.